Background: Pericytes are multifunctional cells surrounding capillaries and postcapillary venules. In brain microvasculature, pericytes play a pivotal role under physiological and pathological conditions by producing reactive oxygen species (ROS). The aims of this study were to elucidate the source of ROS and its regulation in human brain pericytes. Methods: The expression of Nox enzymes in the cells was evaluated using RT-PCR and western blot. Superoxide production was determined by superoxide dismutase-inhibitable chemiluminescence. Silencing of Nox4 was performed using RNAi, and cell proliferation was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Results: Nox4 was predominant among the Nox family in human brain pericytes. Membrane fractions of cells produced superoxide in the presence of NAD(P)H. Superoxide production was almost abolished with diphenileneiodonium, a Nox inhibitor; however, inhibitors of other possible superoxide-producing enzymes had no effect on NAD(P)H-dependent superoxide production. Pericytes expressed angiotensin II (Ang II) receptors, and Ang II upregulated Nox4 expression. Hypoxic conditions also increased the Nox4 expression. Silencing of Nox4 significantly reduced ROS production and attenuated cell proliferation. Conclusion: Our study showed that Nox4 is a major superoxide-producing enzyme and that its expression is regulated by Ang II and hypoxic stress in human brain pericytes. In addition, Nox4 may promote cell growth.

Journal Section:
Editor's choice
Keywords:
Pericytes, NADPH oxidase, Nox4, Reactive oxygen species, Proliferation, Angiogenesis, Angiotensin II, Hypoxia, Brain ischemia
1.
Shepro D, Morel NM: Pericyte physiology. FASEB J 1993;7:1031-1038.
[PubMed]
2.
Armulik A, Abramsson A, Betsholtz C: Endothelial/pericyte interactions. Circ Res 2005;97:512-523.
[PubMed]
https://doi.org/10.1161/01.RES.0000182903.16652.d7
3.
Kutcher ME, Herman IM: The pericyte: cellular regulator of microvascular blood flow. Microvasc Res 2009;77:235-246.
[PubMed]
https://doi.org/10.1016/j.mvr.2009.01.007
4.
Frank RN, Dutta S, Mancini MA: Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Invest Ophthalmol Vis Sci 1987;28:1086-1091.
[PubMed]
5.
Kamouchi M, Ago T, Kitazono T: Brain pericytes: emerging concepts and functional roles in brain homeostasis. Cell Mol Neurobiol 2011;31:175-193.
[PubMed]
https://doi.org/10.1007/s10571-010-9605-x
6.
Kamouchi M, Ago T, Kuroda J, Kitazono T: The possible roles of brain pericytes in brain ischemia and stroke. Cell Mol Neurobiol 2012;32:159-165.
[PubMed]
https://doi.org/10.1007/s10571-011-9747-5
7.
Fisher M: Pericyte signaling in the neurovascular unit. Stroke 2009;40:S13-S15.
[PubMed]
https://doi.org/10.1161/STROKEAHA.108.533117
8.
Bergers G, Song S: The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005;7:452-464.
[PubMed]
https://doi.org/10.1215/S1152851705000232
9.
Rucker HK, Wynder HJ, Thomas WE: Cellular mechanisms of CNS pericytes. Brain Res Bull 2000;51:363-369.
[PubMed]
https://doi.org/10.1016/S0361-9230(99)00260-9
10.
Manea A: NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res 2010;342:325-339.
[PubMed]
https://doi.org/10.1007/s00441-010-1060-y
11.
Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H: Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A-11A.
[PubMed]
https://doi.org/10.1016/S0002-9149(02)03144-2
12.
Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478.
[PubMed]
https://doi.org/10.1152/physrev.00047.2003
13.
Ago T, Kuroda J, Kamouchi M, Sadoshima J, Kitazono T: Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. Circ J 2011;75:1791-1800.
[PubMed]
https://doi.org/10.1253/circj.CJ-11-0388
14.
Brandes RP, Weissmann N, Schroder K: NADPH oxidases in cardiovascular disease. Free Radic Biol Med 2010;49:687-706.
[PubMed]
https://doi.org/10.1016/j.freeradbiomed.2010.04.030
15.
Rivera J, Sobey CG, Walduck AK, Drummond GR: Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 2010;15:50-63.
[PubMed]
https://doi.org/10.1179/174329210X12650506623401
16.
Wolin MS, Ahmad M, Gupte SA: The sources of oxidative stress in the vessel wall. Kidney Int 2005;67:1659-1661.
[PubMed]
https://doi.org/10.1111/j.1523-1755.2005.00257.x
17.
Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313.
[PubMed]
https://doi.org/10.1152/physrev.00044.2005
18.
Sumimoto H: Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 2008;275:3249-3277.
[PubMed]
https://doi.org/10.1111/j.1742-4658.2008.06488.x
19.
Lambeth JD: Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-189.
[PubMed]
https://doi.org/10.1038/nri1312
20.
Ago T, Kitazono T, Kuroda J, Kumai Y, Kamouchi M, Ooboshi H, Wakisaka M, Kawahara T, Rokutan K, Ibayashi S, Iida M: NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 2005;36:1040-1046.
[PubMed]
https://doi.org/10.1161/01.STR.0000163111.05825.0b
21.
Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, Iida M: Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004;109:227-233.
[PubMed]
https://doi.org/10.1161/01.CIR.0000105680.92873.70
22.
Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, Kuribayashi F, Imajoh-Ohmi S, Igarashi K, Shibata Y, Sueishi K, Sumimoto H: The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005;10:1139-1151.
[PubMed]
https://doi.org/10.1111/j.1365-2443.2005.00907.x
23.
Arimura K, Ago T, Kamouchi M, Nakamura K, Ishitsuka K, Kuroda J, Sugimori H, Ooboshi H, Sasaki T, Kitazono T: PDGF receptor beta signaling in pericytes following ischemic brain injury. Curr Neurovasc Res 2012;9:1-9.
[PubMed]
https://doi.org/10.2174/156720212799297100
24.
Tokami H, Ago T, Sugimori H, Kuroda J, Awano H, Suzuki K, Kiyohara Y, Kamouchi M, Kitazono T; REBIOS Investigators: RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke. Brain Res 2013;1517:122-132.
[PubMed]
https://doi.org/10.1016/j.brainres.2013.04.022
25.
Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, Sumimoto H: A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 2001;276:1417-1423.
[PubMed]
https://doi.org/10.1074/jbc.M007597200
26.
Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J: NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A 2010;107:15565-15570.
[PubMed]
https://doi.org/10.1073/pnas.1002178107
27.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
[PubMed]
https://doi.org/10.1038/35078107
28.
Manea A, Raicu M, Simionescu M: Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose. Biol Cell 2005;97:723-734.
[PubMed]
https://doi.org/10.1042/BC20040107
29.
Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo K, Kim JS: Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic Biol Med 2012;53:357-365.
[PubMed]
https://doi.org/10.1016/j.freeradbiomed.2012.04.030
30.
Mustapha NM, Tarr JM, Kohner EM, Chibber R: NADPH oxidase versus mitochondria-derived ROS in glucose-induced apoptosis of pericytes in early diabetic retinopathy. J Ophthalmol 2010;2010:746978.
[PubMed]
https://doi.org/10.1155/2010/746978
31.
Faraci FM: Protecting against vascular disease in brain. Am J Physiol Heart Circ Physiol 2011;300:H1566-H1582.
[PubMed]
https://doi.org/10.1152/ajpheart.01310.2010
32.
Dalkara T, Gursoy-Ozdemir Y, Yemisci M: Brain microvascular pericytes in health and disease. Acta Neuropathol 2011;122:1-9.
[PubMed]
https://doi.org/10.1007/s00401-011-0847-6
33.
Allen CL, Bayraktutan U: Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 2009;4:461-470.
[PubMed]
https://doi.org/10.1111/j.1747-4949.2009.00387.x
34.
Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T: Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009;15:1031-1037.
[PubMed]
https://doi.org/10.1038/nm.2022
35.
Geiszt M, Kopp JB, Varnai P, Leto TL: Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 2000;97:8010-8014.
[PubMed]
https://doi.org/10.1073/pnas.130135897
36.
Lassegue B, Griendling KK: NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010;30:653-661.
[PubMed]
https://doi.org/10.1161/ATVBAHA.108.181610
37.
Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD: Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999;401:79-82.
[PubMed]
https://doi.org/10.1038/43459
© 2015 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.